CanniMed Therapeutics Inc.

Financial Advisors, Investment Advisors, Analysts, and Institutional Portfolio Managers are cordially invited to attend a presentation for: Corporate Presentation In New York
May 9, 2017 - 12:00 PM EDT
Metlife Building (Vanderbilt Suites) - 200 Park Avenue, New York, New York

The Company is a Canadian-based, international plant biopharmaceutical company and leader in the Canadian medical cannabis industry, with 15 years’ of pharmaceutical cannabis cultivation experience, state-of-the-art, a GMP-compliant production process, including 281 points of quality control and world class research and development platforms with a wide range of pharmaceutical-grade cannabis products.

The Company also has an active plant biotechnology research and product development program focused on the production of plant-based materials for pharmaceutical, agricultural and environmental applications.